Press Releases

MediPharm Labs Receives Organic Certification for Cannabis Oil and Extracts for Medical- and Adult-Use Markets

Sep 20, 2019

MediPharm Labs and Cronos Group Enter Private Label Contract Manufacturing Agreement

Sep 19, 2019

MediPharm Labs Enters into Agreements with Australian Licensed Producer & Forms Multiple Cannabis Supply Partnerships to Advance Australian Market Leadership

Sep 3, 2019

MediPharm Labs Announces Participation at Upcoming Conferences

Aug 29, 2019

MediPharm Labs Appoints Renowned Cannabis Researcher Dr. Landolt-Marticorena, MD, PhD, to its Science Advisory Committee

Aug 20, 2019

MediPharm Labs Reports Strong, Profitable Second Quarter Results

Aug 12, 2019

MediPharm Labs Sets Date to Announce Second Quarter 2019 Financial Results

Aug 1, 2019

MediPharm Labs Announces Trading Date on the Toronto Stock Exchange

Jul 25, 2019

MediPharm Labs Conditionally Approved to Graduate to the TSX

Jul 18, 2019

MediPharm Labs Provides Operational Update and Increases Average Weekly Production of Active Cannabinoid Component to 75 Million Milligrams

Jul 16, 2019